C. Spencer

发表

Maternal antibodies to Ro (SS-A) are associated with both early onset of disease and male sex among children with systemic lupus erythematosus.

T. Santner, J. Harley, R. Petty, 1989, Arthritis and rheumatism.

Are patient surveys valuable as a service-improvement tool in health services? An overview

C. Spencer, A. Patwardhan, 2012 .

The use of a mandatory best practice reminder in the electronic record improves influenza vaccination rate in a pediatric rheumatology clinic

K. Kelleher, J. Menke, C. Spencer, 2011 .

Lupus Anticoagulant and Thrombosis Following Henoch

D. Licht, N. Abend, C. Spencer, 2007 .

Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.

D. McCurdy, L. Wagner-Weiner, T. Moore, 2003, The Journal of rheumatology.

Immunogenetic studies of juvenile dermatomyositis

O. Jonasson, C. Fink, J. Friedman, 2008 .

Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies.

J. Friedman, L. Pachman, W. Crowe, 1983, Arthritis and rheumatism.

Immunogenetic studies of juvenile dermatomyositis. HLA antigens in patients and their families.

O. Jonasson, C. Fink, J. Friedman, 1983, Tissue antigens.

Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.

A. Reiff, A. Martini, A. Pistorio, 2003, Arthritis and rheumatism.

Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM

C. Spencer, A. Patwardhan, 2021, Modern rheumatology.

Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease

L. Rider, A. Huber, M. Curran, 2017, Pediatric Rheumatology.

Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center’s experience

I. Dvorchik, C. Spencer, A. Patwardhan, 2012, Pediatric Rheumatology.

Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis.

A. Poznanski, L. Wagner-Weiner, E. Ekwo, 1993, Arthritis and rheumatism.

Course of treated juvenile dermatomyositis.

B. Bernstein, K. King, V. Hanson, 1984, The Journal of pediatrics.

Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash

B. Feldman, A. Huber, J. Weiss, 2017, The Journal of Rheumatology.

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

C. Spencer, A. Patwardhan, 2019, Pediatric rheumatology online journal.

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America

H. Kim, P. Ferguson, R. Sundel, 2017, Pediatric Rheumatology.

A Multicenter Case-Control Study on Predictive Factors Distinguishing Childhood Leukemia From Juvenile Rheumatoid Arthritis

S. Bowyer, C. Rabinovich, B. Gottlieb, 2006, Pediatrics.

Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer

C. Spencer, P. Malleson, M. Sailer-Hoeck, 2010, Pediatric rheumatology online journal.

953 IMMUNOGENETICS OF JUVENILE DERMATOMYOSITIS (JDMS), A COLLABORATIVE STUDY

O. Jonasson, C. Fink, J. Friedman, 1981, Pediatric Research.

Hip disease in juvenile rheumatoid arthritis

B. Bernstein, C. Spencer, 2002, Current opinion in rheumatology.

Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.

J. Baum, E. Giannini, L. Zemel, 1991, The Journal of rheumatology.

The child with arthritis in the school setting.

M. Passo, C. Spencer, J. Zanga, 1986, Pediatric clinics of North America.

Quantitative evaluation of a pediatric rheumatology transition program

C. Spencer, G. Higgins, S. Ardoin, 2015, Pediatric Rheumatology.

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)

B. Adler, Katherine E. Lintner, Chack-Yung Yu, 2017, Pediatric Rheumatology.

Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura.

D. Licht, N. Abend, C. Spencer, 2007, Pediatric neurology.

Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations

H. Nagaraja, C. Lau, Katherine E. Lintner, 2016, Arthritis & rheumatology.

Assessment of transition readiness in adolescents and young adults with chronic health conditions

B. Boyle, M. Kamboj, C. Spencer, 2017, Pediatric Rheumatology.

Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus

S. O’Brien, J. Stanek, C. Spencer, 2016, Lupus.

Why should pediatric rheumatology be recognized as a separate subspecialty: an open letter to medical councils and government agencies

C. Spencer, 2007, Pediatric rheumatology online journal.

Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis

N. Wulffraat, G. Coppa, C. Thorne, 2009, Pediatric rheumatology online journal.

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases

C. Y. Yu, L. Hebert, Yee-Ling Wu, 2016, Front. Immunol..

Pediatric Rheumatology for the Primary Care Clinicians-Recognizing Patterns of Disease.

C. Spencer, A. Patwardhan, 2015, Current problems in pediatric and adolescent health care.

Pediatric Rheumatology – a continuation of Pediatric Rheumatology Online Journal

A. Martini, C. Spencer, 2007, Pediatric rheumatology online journal.

Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis

L. Padyukov, Yee-Ling Wu, F. Miller, 2015, Annals of the rheumatic diseases.

The school experience of children with arthritis. Coping in the 1990s and transition into adulthood.

C. Spencer, C. Rabinovich, R. Z. Fife, 1995, Pediatric clinics of North America.

School attendance and patterns, special services and special needs in pediatric patients with rheumatic diseases: Results of a multicenter study

P. White, B. Athreya, D. Lovell, 1990 .

Age and fecal microbial strain-specific differences in patients with spondyloarthritis

M. Danila, E. Lefkowitz, A. Reiff, 2018, Arthritis Research & Therapy.

Current pediatric rheumatology fellowship training in the United States: what fellows actually do

M. Henrickson, C. Spencer, A. Patwardhan, 2014, Pediatric Rheumatology.

Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.

A. Reiff, I. Szer, C. Spencer, 2001, The Journal of rheumatology.

An unprecedented COPA gene mutation in two patients in the same family: comparative clinical analysis of newly reported patients with other known COPA gene mutations

C. Spencer, A. Patwardhan, 2019, Pediatric Rheumatology.

A. Reiff, A. Martini, A. Pistorio, 2004, Arthritis and rheumatism.

Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance

H. Tory, C. Spencer, G. Syverson, 2023, Pediatric Rheumatology.